Promising research results on the detection of prostate cancer by QBIN members Brigitte Guérin and Éric Turcotte has been mentioned in the media.
A new approach to detecting prostate cancer
The strength of research combining with clinical practice is a unique advantage that the CIUSSS de l’Estrie – CHUS offers to users. The result: a new approach to accurately detect prostate cancer cells is added to the already available clinical tests. Using the 68Ga-PSMA-617 radiotracer, produced by the Sherbrooke Molecular Imaging Centre (CIMS) at the CHUS Research Centre (CRCHUS), 500 men will benefit for the first year. this new positron emission tomography (PET) imaging exam.